PMC Stock Chart & Stats
€90.00
€2.00(1.26%)
At close: 4:00 PM EST
€90.00
€2.00(1.26%)
Day’s Range― - ―
52-Week Range€63.00 - €187.00
Previous CloseN/A
Volume88.00
Average Volume (3M)79.00
Market Cap
€13.44B
Enterprise Value€17.90B
Total Cash (Recent Filing)€223.59M
Total Debt (Recent Filing)€4.32M
Price to Earnings (P/E)91.9
Beta0.98
Next Earnings
Aug 19, 2026EPS Estimate
0.57Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.25
Shares Outstanding104,469,960
10 Day Avg. Volume131
30 Day Avg. Volume79
Financial Highlights & Ratios
PEG Ratio6.60
Price to Book (P/B)115.91
Price to Sales (P/S)139.89
P/FCF Ratio286.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€126.00Price Target Upside40.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)1.09
Revenue Forecast (FY)€204.56M
Bulls Say, Bears Say
Bulls Say
Market AcceptanceOver 55% of surveyed US hospital executives are likely to deploy Pro Medicus's Visage 7 software, highlighting strong market acceptance and growth potential.
Product InnovationThe Visage 7 software from Pro Medicus creates significant value for customers, making it 60-70% faster than legacy solutions and boosting customer volumes significantly.
Bears Say
Market PenetrationPME's share of the US market remains low at 7%, which highlights the opportunity ahead, notwithstanding upside prospects from the core TAM, adjacencies and potential new markets.
Pro Medicus Limited News
PMC FAQ
What was Pro Medicus Limited’s price range in the past 12 months?
Pro Medicus Limited lowest stock price was €63.00 and its highest was €187.00 in the past 12 months.
What is Pro Medicus Limited’s market cap?
Pro Medicus Limited’s market cap is €13.44B.
When is Pro Medicus Limited’s upcoming earnings report date?
Pro Medicus Limited’s upcoming earnings report date is Aug 19, 2026 which is in 40 days.
How were Pro Medicus Limited’s earnings last quarter?
Pro Medicus Limited released its earnings results on Feb 11, 2026. The company reported €0.992 earnings per share for the quarter, beating the consensus estimate of €0.401 by €0.591.
Is Pro Medicus Limited overvalued?
According to Wall Street analysts Pro Medicus Limited’s price is currently Undervalued.
Does Pro Medicus Limited pay dividends?
Pro Medicus Limited does not currently pay dividends.
What is Pro Medicus Limited’s EPS estimate?
Pro Medicus Limited’s EPS estimate is 0.57.
How many shares outstanding does Pro Medicus Limited have?
Pro Medicus Limited has 104,469,960 shares outstanding.
What happened to Pro Medicus Limited’s price movement after its last earnings report?
Pro Medicus Limited reported an EPS of €0.992 in its last earnings report, beating expectations of €0.401. Following the earnings report the stock price went down -20.812%.
Which hedge fund is a major shareholder of Pro Medicus Limited?
Currently, no hedge funds are holding shares in DE:PMC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pro Medicus Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€126.00 (40.00% Upside)
€126.00 (40.00% Upside)
Blogger Sentiment
Bullish
DE:PMC Sentiment 95%
Sector Average 69%
Sector Average 69%
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.79%
12-Months-Change
Fundamentals
Return on Equity
72.67%
Trailing 12-Months
Asset Growth
95.48%
Trailing 12-Months
Company Description
Pro Medicus Limited
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
PMC Company Deck
PMC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with record revenue and profit growth, significant contract wins, and advancements in cloud and AI technology. However, challenges remain in expanding market penetration outside North America and navigating a competitive landscape.View all DE:PMC earnings summariesPMC Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€126.00
▲(40.00% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Singular Health Group Ltd
―
Artrya Limited
―
Alcidion Group Limited
―
Options Prices
Currently, No data available
---









